IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $35,072,000 | -65.9% | 3,176,773 | -48.6% | 0.19% | -61.5% |
Q1 2022 | $102,820,000 | -11.1% | 6,175,357 | +1.9% | 0.50% | -14.2% |
Q4 2021 | $115,723,000 | -12.1% | 6,061,973 | +13.5% | 0.58% | -6.0% |
Q3 2021 | $131,684,000 | -3.6% | 5,339,994 | +1.7% | 0.62% | +10.2% |
Q2 2021 | $136,605,000 | -9.2% | 5,250,000 | +10.5% | 0.56% | -25.3% |
Q1 2021 | $150,385,000 | -46.0% | 4,750,000 | -20.8% | 0.75% | -55.4% |
Q4 2020 | $278,400,000 | +42.0% | 6,000,000 | +0.8% | 1.67% | +23.5% |
Q3 2020 | $196,039,000 | +9.2% | 5,955,000 | -8.9% | 1.36% | -5.6% |
Q2 2020 | $179,454,000 | +4.3% | 6,537,500 | +13.7% | 1.44% | -2.8% |
Q1 2020 | $172,126,000 | -0.5% | 5,750,000 | -8.0% | 1.48% | +26.5% |
Q4 2019 | $173,000,000 | +57.8% | 6,250,000 | +3.7% | 1.17% | +41.1% |
Q3 2019 | $109,655,000 | -21.9% | 6,025,000 | +5.2% | 0.83% | -9.3% |
Q2 2019 | $140,377,000 | +157.8% | 5,725,000 | 0.0% | 0.91% | +123.2% |
Q1 2019 | $54,445,000 | +7.5% | 5,725,000 | 0.0% | 0.41% | +10.2% |
Q4 2018 | $50,666,000 | -4.7% | 5,725,000 | +21.2% | 0.37% | +18.2% |
Q3 2018 | $53,156,000 | -6.2% | 4,725,000 | +6.8% | 0.31% | -10.3% |
Q2 2018 | $56,640,000 | -19.2% | 4,425,000 | +6.6% | 0.35% | -28.0% |
Q1 2018 | $70,135,000 | +369.6% | 4,150,000 | +122.3% | 0.49% | +301.7% |
Q4 2017 | $14,935,000 | +126.7% | 1,866,900 | +119.6% | 0.12% | +105.1% |
Q3 2017 | $6,588,000 | – | 850,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |